DARE · Dare Bioscience, Inc.
Trades by corporate insiders — officers, directors and holders of more than 10% of the shares — disclosed to the SEC on Forms 3, 4 and 5. Form 4 must be filed within two business days of the trade.
| Date | Insider | Role | Type | Security | Shares |
|---|---|---|---|---|---|
| 2026-06-30 | Matz Gregory W |
Director |
Award↑
Filing footnotes — Common stock (Direct)
Represents shares underlying restricted stock units ("RSU") granted to the reporting person in lieu of cash compensation for service on the issuer's board of directors and its committees. Each RSU represents a contingent right to receive one share when vested. The RSUs vests on January 4, 2027. |
Common stock
|
30,805 |
| 2026-06-30 | Grossman Jessica D. |
Director |
Award↑
Filing footnotes — Common stock (Direct)
Represents shares underlying restricted stock units ("RSU") granted to the reporting person in lieu of cash compensation for service on the issuer's board of directors and its committees. Each RSU represents a contingent right to receive one share when vested. The RSUs vests on January 4, 2027. |
Common stock
|
26,066 |
| 2026-06-30 | Steele Robin Joan |
Director |
Award↑
Filing footnotes — Common stock (Direct)
Represents shares underlying restricted stock units ("RSU") granted to the reporting person in lieu of cash compensation for service on the issuer's board of directors and its committees. Each RSU represents a contingent right to receive one share when vested. The RSUs vests on January 4, 2027. |
Common stock
|
26,540 |
| 2026-06-30 | Kelley Susan L. |
Director |
Award↑
Filing footnotes — Common stock (Direct)
Represents shares underlying restricted stock units ("RSU") granted to the reporting person in lieu of cash compensation for service on the issuer's board of directors and its committees. Each RSU represents a contingent right to receive one share when vested. The RSUs vests on January 4, 2027. |
Common stock
|
23,696 |
| 2026-06-30 | RASTETTER WILLIAM H |
Director |
Award↑
Filing footnotes — Common stock (Direct)
Represents shares underlying restricted stock units ("RSU") granted to the reporting person in lieu of cash compensation for service on the issuer's board of directors and its committees. Each RSU represents a contingent right to receive one share when vested. The RSUs vests on January 4, 2027. |
Common stock
|
38,862 |
| 2026-06-11 | Grossman Jessica D. |
Director |
Award↑
Filing footnotes — Stock Option (right to buy) (Direct)
This option will vest in full on the earlier of the first anniversary of the grant date or immediately prior to the issuer's first annual meeting of stockholders occurring after the grant date, subject to the director's continued service as a director, and will become exercisable in full upon a change in control of the issuer. |
Stock Option (right to buy)
|
10,000 |
| 2026-06-11 | RASTETTER WILLIAM H |
Director |
Award↑
Filing footnotes — Stock Option (right to buy) (Direct)
This option will vest in full on the earlier of the first anniversary of the grant date or immediately prior to the issuer's first annual meeting of stockholders occurring after the grant date, subject to the director's continued service as a director, and will become exercisable in full upon a change in control of the issuer. |
Stock Option (right to buy)
|
10,000 |
| 2026-06-11 | Matz Gregory W |
Director |
Award↑
Filing footnotes — Stock Option (right to buy) (Direct)
This option will vest in full on the earlier of the first anniversary of the grant date or immediately prior to the issuer's first annual meeting of stockholders occurring after the grant date, subject to the director's continued service as a director, and will become exercisable in full upon a change in control of the issuer. |
Stock Option (right to buy)
|
10,000 |
| 2026-06-11 | Kelley Susan L. |
Director |
Award↑
Filing footnotes — Stock Option (right to buy) (Direct)
This option will vest in full on the earlier of the first anniversary of the grant date or immediately prior to the issuer's first annual meeting of stockholders occurring after the grant date, subject to the director's continued service as a director, and will become exercisable in full upon a change in control of the issuer. |
Stock Option (right to buy)
|
10,000 |
| 2026-06-11 | Steele Robin Joan |
Director |
Award↑
Filing footnotes — Stock Option (right to buy) (Direct)
This option will vest in full on the earlier of the first anniversary of the grant date or immediately prior to the issuer's first annual meeting of stockholders occurring after the grant date, subject to the director's continued service as a director, and will become exercisable in full upon a change in control of the issuer. |
Stock Option (right to buy)
|
10,000 |
| 2026-02-18 | JOHNSON SABRINA MARTUCCI |
Director |
Award↑
Filing footnotes — Common Stock Warrant (right to buy) (Direct)
This date is the date on which the reporting person subscribed to purchase the securities. The securities will be issued at a future date when the Issuer accepts the reporting person's subscription. The reported securities are included within 10,800 Investor Units (the Units) purchased by the reporting person in the Regulation A offering of the Issuer for $5 per Unit. Each Unit consists of one share of Preferred Stock, each of which is initially convertible into two shares of Common Stock, and two warrants, each to purchase one share of Common Stock. This security is convertible or exercisable, as applicable, at any time after issuance. This security expires on the 36-month anniversary of the date of issuance. |
Common Stock Warrant (right to buy)
|
21,600 |
| 2026-02-18 | JOHNSON SABRINA MARTUCCI |
Director |
Award↑
Filing footnotes — Series A Convertible Preferred Stock (Direct)
This date is the date on which the reporting person subscribed to purchase the securities. The securities will be issued at a future date when the Issuer accepts the reporting person's subscription. The reported securities are included within 10,800 Investor Units (the Units) purchased by the reporting person in the Regulation A offering of the Issuer for $5 per Unit. Each Unit consists of one share of Preferred Stock, each of which is initially convertible into two shares of Common Stock, and two warrants, each to purchase one share of Common Stock. This security is convertible or exercisable, as applicable, at any time after issuance. The Series A Convertible Preferred Stock (the Preferred Stock) is perpetual and has no expiration date. The Issuer has the option to redeem the Preferred Stock and the right to require the conversion of the Preferred Stock into shares of the common stock of the Issuer (the Common Stock), in each case, subject to specified conditions. |
Series A Convertible Preferred Stock
|
10,800 |
| 2026-01-30 | Haring-Layton MarDee |
Chief Accounting Officer |
Award↑
Filing footnotes — Employee Stock Option (right to buy) (Direct)
This stock option vests and becomes exercisable in 48 equal monthly installments commencing on the one-month anniversary of the grant date, subject to the reporting person's continuous service to the issuer. |
Employee Stock Option (right to buy)
|
49,000 |
| 2026-01-30 | JOHNSON SABRINA MARTUCCI |
Director |
Award↑
Filing footnotes — Employee Stock Option (right to buy) (Direct)
This stock option vests and becomes exercisable in 48 equal monthly installments commencing on the one-month anniversary of the grant date, subject to the reporting person's continuous service to the issuer. |
Employee Stock Option (right to buy)
|
172,000 |
| 2025-09-04 | Haring-Layton MarDee |
Chief Accounting Officer |
Award↑
Filing footnotes — Employee Stock Option (right to buy) (Direct)
This stock option was granted to the reporting person as a retention award and vests and becomes exercisable on 9/4/2027, provided, that, if certain performance criteria are satisfied, it will vest and become exercisable on the date such performance criteria are satisfied, subject to the reporting person's continuous service to the issuer. |
Employee Stock Option (right to buy)
|
57,000 |
| 2025-07-09 | RASTETTER WILLIAM H |
Director |
Award↑
Filing footnotes — Stock Option (right to buy) (Direct)
This option will vest in full on the earlier of the first anniversary of the grant date or immediately prior to the issuer's first annual meeting of stockholders occurring after the grant date, subject to the director's continued service as a director, and will become exercisable in full upon a change in control of the issuer. |
Stock Option (right to buy)
|
4,500 |
| 2025-07-09 | Kelley Susan L. |
Director |
Award↑
Filing footnotes — Stock Option (right to buy) (Direct)
This option will vest in full on the earlier of the first anniversary of the grant date or immediately prior to the issuer's first annual meeting of stockholders occurring after the grant date, subject to the director's continued service as a director, and will become exercisable in full upon a change in control of the issuer. |
Stock Option (right to buy)
|
4,500 |
| 2025-07-09 | Matz Gregory W |
Director |
Award↑
Filing footnotes — Stock Option (right to buy) (Direct)
This option will vest in full on the earlier of the first anniversary of the grant date or immediately prior to the issuer's first annual meeting of stockholders occurring after the grant date, subject to the director's continued service as a director, and will become exercisable in full upon a change in control of the issuer. |
Stock Option (right to buy)
|
4,500 |
| 2025-07-09 | Steele Robin Joan |
Director |
Award↑
Filing footnotes — Stock Option (right to buy) (Direct)
This option will vest in full on the earlier of the first anniversary of the grant date or immediately prior to the issuer's first annual meeting of stockholders occurring after the grant date, subject to the director's continued service as a director, and will become exercisable in full upon a change in control of the issuer. |
Stock Option (right to buy)
|
4,500 |
| 2025-07-09 | Grossman Jessica D. |
Director |
Award↑
Filing footnotes — Stock Option (right to buy) (Direct)
This option will vest in full on the earlier of the first anniversary of the grant date or immediately prior to the issuer's first annual meeting of stockholders occurring after the grant date, subject to the director's continued service as a director, and will become exercisable in full upon a change in control of the issuer. |
Stock Option (right to buy)
|
4,500 |
| 2025-01-28 | Haring-Layton MarDee |
Chief Accounting Officer |
Award↑
Filing footnotes — Employee Stock Option (right to buy) (Direct)
This stock option vests and becomes exercisable in 48 equal monthly installments commencing on the one-month anniversary of the grant date, subject to the reporting person's continuous service to the issuer. |
Employee Stock Option (right to buy)
|
38,000 |
| 2025-01-28 | JOHNSON SABRINA MARTUCCI |
Director |
Award↑
Filing footnotes — Employee Stock Option (right to buy) (Direct)
This stock option vests and becomes exercisable in 48 equal monthly installments commencing on the one-month anniversary of the grant date, subject to the reporting person's continuous service to the issuer. |
Employee Stock Option (right to buy)
|
107,000 |
| 2024-06-05 | Matz Gregory W |
Director |
Award↑
Filing footnotes — Stock Option (right to buy) (Direct)
This option will vest in full on the earlier of the first anniversary of the grant date or immediately prior to the issuer's first annual meeting of stockholders occurring after the grant date, subject to the director's continued service as a director, and will become exercisable in full upon a change in control of the issuer. |
Stock Option (right to buy)
|
40,000 |
| 2024-06-05 | Grossman Jessica D. |
Director |
Award↑
Filing footnotes — Stock Option (right to buy) (Direct)
This option will vest in full on the earlier of the first anniversary of the grant date or immediately prior to the issuer's first annual meeting of stockholders occurring after the grant date, subject to the director's continued service as a director, and will become exercisable in full upon a change in control of the issuer. |
Stock Option (right to buy)
|
40,000 |
| 2024-06-05 | Steele Robin Joan |
Director |
Award↑
Filing footnotes — Stock Option (right to buy) (Direct)
This option will vest in full on the earlier of the first anniversary of the grant date or immediately prior to the issuer's first annual meeting of stockholders occurring after the grant date, subject to the director's continued service as a director, and will become exercisable in full upon a change in control of the issuer. |
Stock Option (right to buy)
|
40,000 |
| 2024-06-05 | RASTETTER WILLIAM H |
Director |
Award↑
Filing footnotes — Stock Option (right to buy) (Direct)
This option will vest in full on the earlier of the first anniversary of the grant date or immediately prior to the issuer's first annual meeting of stockholders occurring after the grant date, subject to the director's continued service as a director, and will become exercisable in full upon a change in control of the issuer. |
Stock Option (right to buy)
|
40,000 |
| 2024-06-05 | Kelley Susan L. |
Director |
Award↑
Filing footnotes — Stock Option (right to buy) (Direct)
This option will vest in full on the earlier of the first anniversary of the grant date or immediately prior to the issuer's first annual meeting of stockholders occurring after the grant date, subject to the director's continued service as a director, and will become exercisable in full upon a change in control of the issuer. |
Stock Option (right to buy)
|
40,000 |
| 2024-03-12 | Fair John A |
Chief Commercial Officer |
Award↑
Filing footnotes — Employee Stock Option (right to buy) (Direct)
This stock option vests and becomes exercisable in 48 equal monthly installments commencing on the one-month anniversary of the grant date, subject to the reporting person's continuous service to the issuer. |
Employee Stock Option (right to buy)
|
290,000 |
| 2024-03-12 | Haring-Layton MarDee |
Chief Accounting Officer |
Award↑
Filing footnotes — Employee Stock Option (right to buy) (Direct)
This stock option vests and becomes exercisable in 48 equal monthly installments commencing on the one-month anniversary of the grant date, subject to the reporting person's continuous service to the issuer. |
Employee Stock Option (right to buy)
|
290,000 |
| 2024-03-12 | JOHNSON SABRINA MARTUCCI |
Director |
Award↑
Filing footnotes — Employee Stock Option (right to buy) (Direct)
This stock option vests and becomes exercisable in 48 equal monthly installments commencing on the one-month anniversary of the grant date, subject to the reporting person's continuous service to the issuer. |
Employee Stock Option (right to buy)
|
750,000 |
| 2023-06-21 | Blanchard Cheryl R |
Director |
Award↑
Filing footnotes — Stock Option (right to buy) (Direct)
This option will vest in full on the earlier of the first anniversary of the grant date or immediately prior to the issuer's first annual meeting of stockholders occurring after the grant date, subject to the director's continued service as a director, and will become exercisable in full upon a change in control of the issuer. |
Stock Option (right to buy)
|
40,000 |
| 2023-06-21 | Matz Gregory W |
Director |
Award↑
Filing footnotes — Stock Option (right to buy) (Direct)
This option will vest in full on the earlier of the first anniversary of the grant date or immediately prior to the issuer's first annual meeting of stockholders occurring after the grant date, subject to the director's continued service as a director, and will become exercisable in full upon a change in control of the issuer. |
Stock Option (right to buy)
|
40,000 |
| 2023-06-21 | Steele Robin Joan |
Director |
Award↑
Filing footnotes — Stock Option (right to buy) (Direct)
This option will vest in full on the earlier of the first anniversary of the grant date or immediately prior to the issuer's first annual meeting of stockholders occurring after the grant date, subject to the director's continued service as a director, and will become exercisable in full upon a change in control of the issuer. |
Stock Option (right to buy)
|
40,000 |
| 2023-06-21 | Grossman Jessica D. |
Director |
Award↑
Filing footnotes — Stock Option (right to buy) (Direct)
This option will vest in full on the earlier of the first anniversary of the grant date or immediately prior to the issuer's first annual meeting of stockholders occurring after the grant date, subject to the director's continued service as a director, and will become exercisable in full upon a change in control of the issuer. |
Stock Option (right to buy)
|
40,000 |
| 2023-06-21 | RASTETTER WILLIAM H |
Director |
Award↑
Filing footnotes — Stock Option (right to buy) (Direct)
This option will vest in full on the earlier of the first anniversary of the grant date or immediately prior to the issuer's first annual meeting of stockholders occurring after the grant date, subject to the director's continued service as a director, and will become exercisable in full upon a change in control of the issuer. |
Stock Option (right to buy)
|
40,000 |
| 2023-06-21 | Kelley Susan L. |
Director |
Award↑
Filing footnotes — Stock Option (right to buy) (Direct)
This option will vest in full on the earlier of the first anniversary of the grant date or immediately prior to the issuer's first annual meeting of stockholders occurring after the grant date, subject to the director's continued service as a director, and will become exercisable in full upon a change in control of the issuer. |
Stock Option (right to buy)
|
40,000 |
| 2023-06-21 | Ononye-Onyia Sophia Nnenna |
Director |
Award↑
Filing footnotes — Stock Option (right to buy) (Direct)
This option will vest in full on the earlier of the first anniversary of the grant date or immediately prior to the issuer's first annual meeting of stockholders occurring after the grant date, subject to the director's continued service as a director, and will become exercisable in full upon a change in control of the issuer. |
Stock Option (right to buy)
|
40,000 |
| 2023-01-24 | Fair John A |
Chief Commercial Officer |
Award↑
Filing footnotes — Stock Option (right to buy) (Direct)
This stock option vests and becomes exercisable in 48 equal monthly installments commencing on the one-month anniversary of the grant date, subject to the reporting person's continuous service to the issuer. |
Stock Option (right to buy)
|
290,000 |
| 2023-01-24 | Walters-Hoffert Lisa |
Director |
Award↑
Filing footnotes — Stock Option (right to buy) (Direct)
This stock option vests and becomes exercisable in 48 equal monthly installments commencing on the one-month anniversary of the grant date, subject to the reporting person's continuous service to the issuer. |
Stock Option (right to buy)
|
290,000 |
| 2023-01-24 | JOHNSON SABRINA MARTUCCI |
Director |
Award↑
Filing footnotes — Stock Option (right to buy) (Direct)
This stock option vests and becomes exercisable in 48 equal monthly installments commencing on the one-month anniversary of the grant date, subject to the reporting person's continuous service to the issuer. |
Stock Option (right to buy)
|
750,000 |
| 2022-06-23 | Kelley Susan L. |
Director |
Award↑
Filing footnotes — Stock Option (right to buy) (Direct)
This option will vest in full on the earlier of the first anniversary of the grant date or immediately prior to the issuer's first annual meeting of stockholders occurring after the grant date, subject to the director's continued service as a director, and will become exercisable in full upon a change in control of the issuer. |
Stock Option (right to buy)
|
38,000 |
| 2022-06-23 | Steele Robin Joan |
Director |
Award↑
Filing footnotes — Stock Option (right to buy) (Direct)
This option will vest in full on the earlier of the first anniversary of the grant date or immediately prior to the issuer's first annual meeting of stockholders occurring after the grant date, subject to the director's continued service as a director, and will become exercisable in full upon a change in control of the issuer. |
Stock Option (right to buy)
|
38,000 |
| 2022-06-23 | Blanchard Cheryl R |
Director |
Award↑
Filing footnotes — Stock Option (right to buy) (Direct)
This option will vest in full on the earlier of the first anniversary of the grant date or immediately prior to the issuer's first annual meeting of stockholders occurring after the grant date, subject to the director's continued service as a director, and will become exercisable in full upon a change in control of the issuer. |
Stock Option (right to buy)
|
38,000 |
| 2022-06-23 | Ononye-Onyia Sophia Nnenna |
Director |
Award↑
Filing footnotes — Stock Option (right to buy) (Direct)
This option will vest in full on the earlier of the first anniversary of the grant date or immediately prior to the issuer's first annual meeting of stockholders occurring after the grant date, subject to the director's continued service as a director, and will become exercisable in full upon a change in control of the issuer. |
Stock Option (right to buy)
|
38,000 |
| 2022-06-23 | RASTETTER WILLIAM H |
Director |
Award↑
Filing footnotes — Stock Option (right to buy) (Direct)
This option will vest in full on the earlier of the first anniversary of the grant date or immediately prior to the issuer's first annual meeting of stockholders occurring after the grant date, subject to the director's continued service as a director, and will become exercisable in full upon a change in control of the issuer. |
Stock Option (right to buy)
|
38,000 |
| 2022-06-23 | Grossman Jessica D. |
Director |
Award↑
Filing footnotes — Stock Option (right to buy) (Direct)
This option will vest in full on the earlier of the first anniversary of the grant date or immediately prior to the issuer's first annual meeting of stockholders occurring after the grant date, subject to the director's continued service as a director, and will become exercisable in full upon a change in control of the issuer. |
Stock Option (right to buy)
|
38,000 |
| 2022-06-23 | Matz Gregory W |
Director |
Award↑
Filing footnotes — Stock Option (right to buy) (Direct)
This option will vest in full on the earlier of the first anniversary of the grant date or immediately prior to the issuer's first annual meeting of stockholders occurring after the grant date, subject to the director's continued service as a director, and will become exercisable in full upon a change in control of the issuer. |
Stock Option (right to buy)
|
38,000 |
| 2022-01-25 | Walters-Hoffert Lisa |
Director |
Award↑
Filing footnotes — Stock Option (right to buy) (Direct)
This stock option vests and becomes exercisable in 48 equal monthly installments commencing on the one-month anniversary of the grant date, subject to the reporting person's continuous service to the issuer. |
Stock Option (right to buy)
|
185,000 |
| 2022-01-25 | Fair John A |
Chief Commercial Officer |
Award↑
Filing footnotes — Stock Option (right to buy) (Direct)
This stock option vests and becomes exercisable in 48 equal monthly installments commencing on the one-month anniversary of the grant date, subject to the reporting person's continuous service to the issuer. |
Stock Option (right to buy)
|
185,000 |
| 2022-01-25 | JOHNSON SABRINA MARTUCCI |
Director |
Award↑
Filing footnotes — Stock Option (right to buy) (Direct)
This stock option vests and becomes exercisable in 48 equal monthly installments commencing on the one-month anniversary of the grant date, subject to the reporting person's continuous service to the issuer. |
Stock Option (right to buy)
|
628,400 |